CTOs on the Move

Able Medical Aids

www.ablemedical.com

 
Able Medical Aids is a Largo, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Juniper Communities

Juniper Communities was founded in 1988 and operates 18 long-term care communities in NJ, FL, PA and CO. Juniper is dedicated to Nurturing the Spirit of Life in each individual served and believes the keys to healthy aging are an active body, an engaged mind, and a fulfilled spirit. The company`s mission is to serve its stakeholders, residents, families, employee associates, and investors with excellence and strong dedication to the company`s hallmarks of quality, value and innovation.

Access Lifts and Ramps

Access Lifts and Ramps is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BIAN

BIÂN is a private members club built on the foundation of holistic wellness, vitality, and social well-being. In one dynamic, design-forward space, we weave Eastern and Western healing philosophies, mental health consultations, concierge medicine, holistic apothecary, extensive fitness, yoga and studio offerings, chef-driven artisanal food and beverage, innovative therapeutic modalities, luxurious spa and beauty services, and programming in our grand social gathering spaces.

Garden View Assisted Living

Garden View Assisted Living is a New Iberia, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immune Pharmaceuticals

Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.